MTNB Matinas BioPharma

Watchlist

0.5760
-0.0130-2.21%

Close Feb 26 16:00 ET

0.5695
-0.0065-1.13%

Post 17:25 ET

2.93MMarket Cap-0.12P/E (TTM)

About Matinas BioPharma Company

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Company Profile

SymbolMTNB

Company NameMatinas BioPharma

Listing DateMar 2, 2017

Founded2013

CEOMr. Jerome D. Jabbour, J.D.

MarketAMEX

Employees32

Fiscal Year Ends12-31

Address1545 Route 206 South,Suite 302

CityBedminster

ProvinceNew Jersey

CountryUnited States of America

Zip Code07921-9999

Phone1-908-484-8805

Websitehttp://www.matinasbiopharma.com

Company Executives

Name
Position
Salary

Jerome D. Jabbour, J.D.
Chief Executive Officer, President and Director
--

Keith A. Kucinski, C.P.A.,M.B.A.
Chief Financial Officer and Principal Accounting Officer
--

Dr. Eric J. Ende, M.B.A.,M.D.
Chairman of the Board
--

Natasha Giordano
Independent Director
--

Evelyn D’An
Independent Director
--

Dr. Matthew A. Wikler, M.B.A.,M.D.
Independent Director
--

Dr. Robin L. Smith, M.B.A.,M.D.
Independent Director
--

MTNB Matinas BioPharma

About Matinas BioPharma Company

Company Profile

Company Executives

Trending Stocks